Does anybody know if typically you get some kind of FDA response / indication of support of lack therof during this meeting prior to the targeted May PDUFA approval ? Just trying to figure out what if any information is typically shared post this meeting so i can plan my investment strategy accordingly. With the large number of March puts changing hands last Friday obviously some people are betting it does not go well so i am trying to determine what the output is. Thanks
If I am not mistaken, the FDA briefing docs should be posted tomorrow, that will determine how THRX does on tuesday and wednesday. The stock may not trade on thursday. With regards to friday's put volume, is it possible that a bullish investor may have sold the puts and pocketed the premium?